Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation

Melissa-Rose Abrahams, Sarah B. Joseph, Nigel Garrett, Lynn Tyers, Matthew Moeser, Nancie Archin, Olivia D. Council, David Matten, Shuntai Zhou, Deelan Doolabh, Colin Anthony, Nilu Goonetilleke, Salim Abdool Karim, David M. Margolis, Sergei Kosakovsky Pond, Carolyn Williamson, Ronald Swanstrom
doi: https://doi.org/10.1101/512475
Melissa-Rose Abrahams
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah B. Joseph
2Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Garrett
4Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynn Tyers
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Moeser
3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancie Archin
5UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia D. Council
2Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Matten
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuntai Zhou
3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deelan Doolabh
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Anthony
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilu Goonetilleke
2Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salim Abdool Karim
4Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
6Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Margolis
5UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergei Kosakovsky Pond
7Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Williamson
1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
8National Health Laboratory Services of South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: risunc@med.unc.edu carolyn.williamson@uct.ac.za
Ronald Swanstrom
3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
9Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: risunc@med.unc.edu carolyn.williamson@uct.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Although antiretroviral therapy (ART) is highly effective at suppressing HIV-1 replication, the virus persists as a latent reservoir in resting CD4+ T cells during therapy. Little is known about the dynamics of reservoir formation and this reservoir forms even when ART is initiated early after infection. The reservoir of individuals who initiate therapy in chronic infection is generally larger and genetically more diverse than that of individuals who initiate in acute infection, suggesting the reservoir is formed continuously throughout untreated infection. To determine when viruses enter the latent reservoir, we compared sequences of replication-competent viruses from resting CD4+ T cells from nine women on therapy to viral sequences circulating in blood collected longitudinally prior to therapy. We found that 78% of viruses from the latent reservoir were most genetically similar to viruses replicating just prior to therapy initiation. This proportion is far greater than expected if the reservoir forms continuously and is always long-lived. Thus, therapy alters the host environment in a way that allows the formation of a majority of the long-lived latent HIV-1 reservoir.

One Sentence Summary Most of the long-lived, replication-competent HIV-1 reservoir is formed at the time of therapy initiation.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 04, 2019.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation
Melissa-Rose Abrahams, Sarah B. Joseph, Nigel Garrett, Lynn Tyers, Matthew Moeser, Nancie Archin, Olivia D. Council, David Matten, Shuntai Zhou, Deelan Doolabh, Colin Anthony, Nilu Goonetilleke, Salim Abdool Karim, David M. Margolis, Sergei Kosakovsky Pond, Carolyn Williamson, Ronald Swanstrom
bioRxiv 512475; doi: https://doi.org/10.1101/512475
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation
Melissa-Rose Abrahams, Sarah B. Joseph, Nigel Garrett, Lynn Tyers, Matthew Moeser, Nancie Archin, Olivia D. Council, David Matten, Shuntai Zhou, Deelan Doolabh, Colin Anthony, Nilu Goonetilleke, Salim Abdool Karim, David M. Margolis, Sergei Kosakovsky Pond, Carolyn Williamson, Ronald Swanstrom
bioRxiv 512475; doi: https://doi.org/10.1101/512475

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4397)
  • Biochemistry (9623)
  • Bioengineering (7118)
  • Bioinformatics (24928)
  • Biophysics (12651)
  • Cancer Biology (9984)
  • Cell Biology (14393)
  • Clinical Trials (138)
  • Developmental Biology (7982)
  • Ecology (12141)
  • Epidemiology (2067)
  • Evolutionary Biology (16020)
  • Genetics (10946)
  • Genomics (14773)
  • Immunology (9896)
  • Microbiology (23730)
  • Molecular Biology (9501)
  • Neuroscience (51035)
  • Paleontology (370)
  • Pathology (1544)
  • Pharmacology and Toxicology (2690)
  • Physiology (4035)
  • Plant Biology (8687)
  • Scientific Communication and Education (1512)
  • Synthetic Biology (2403)
  • Systems Biology (6452)
  • Zoology (1349)